Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: A Southwest Oncology group study

Amy D. Tiersten, James Moon, Harriet O. Smith, Sharon P. Wilczynski, William R. Robinson, Maurie Markman, David S. Alberts

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: A Southwest Oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences